Positron Emission Tomography Imaging of Mu- and Delta-Opioid Receptor Binding in Alcohol-Dependent and Healthy Control Subjects

Authors

  • Elise M. Weerts,

    1. From the Department of Psychiatry and Behavioral Sciences (EMW, GSW, CAM, MEM), The Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Medicine (GSW, MEM), The Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Neuroscience (JJF), The Johns Hopkins University School of Medicine, Baltimore, Maryland; and Department of Radiology (HK, RFD, JH, JJF), The Johns Hopkins University School of Medicine, Baltimore, Maryland; and Department of Neuroscience (JJF), The Johns Hopkins University School of Medicine, Baltimore, Maryland.
    Search for more papers by this author
  • Gary S. Wand,

    1. From the Department of Psychiatry and Behavioral Sciences (EMW, GSW, CAM, MEM), The Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Medicine (GSW, MEM), The Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Neuroscience (JJF), The Johns Hopkins University School of Medicine, Baltimore, Maryland; and Department of Radiology (HK, RFD, JH, JJF), The Johns Hopkins University School of Medicine, Baltimore, Maryland; and Department of Neuroscience (JJF), The Johns Hopkins University School of Medicine, Baltimore, Maryland.
    Search for more papers by this author
  • Hiroto Kuwabara,

    1. From the Department of Psychiatry and Behavioral Sciences (EMW, GSW, CAM, MEM), The Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Medicine (GSW, MEM), The Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Neuroscience (JJF), The Johns Hopkins University School of Medicine, Baltimore, Maryland; and Department of Radiology (HK, RFD, JH, JJF), The Johns Hopkins University School of Medicine, Baltimore, Maryland; and Department of Neuroscience (JJF), The Johns Hopkins University School of Medicine, Baltimore, Maryland.
    Search for more papers by this author
  • Cynthia A. Munro,

    1. From the Department of Psychiatry and Behavioral Sciences (EMW, GSW, CAM, MEM), The Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Medicine (GSW, MEM), The Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Neuroscience (JJF), The Johns Hopkins University School of Medicine, Baltimore, Maryland; and Department of Radiology (HK, RFD, JH, JJF), The Johns Hopkins University School of Medicine, Baltimore, Maryland; and Department of Neuroscience (JJF), The Johns Hopkins University School of Medicine, Baltimore, Maryland.
    Search for more papers by this author
  • Robert F. Dannals,

    1. From the Department of Psychiatry and Behavioral Sciences (EMW, GSW, CAM, MEM), The Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Medicine (GSW, MEM), The Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Neuroscience (JJF), The Johns Hopkins University School of Medicine, Baltimore, Maryland; and Department of Radiology (HK, RFD, JH, JJF), The Johns Hopkins University School of Medicine, Baltimore, Maryland; and Department of Neuroscience (JJF), The Johns Hopkins University School of Medicine, Baltimore, Maryland.
    Search for more papers by this author
  • John Hilton,

    1. From the Department of Psychiatry and Behavioral Sciences (EMW, GSW, CAM, MEM), The Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Medicine (GSW, MEM), The Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Neuroscience (JJF), The Johns Hopkins University School of Medicine, Baltimore, Maryland; and Department of Radiology (HK, RFD, JH, JJF), The Johns Hopkins University School of Medicine, Baltimore, Maryland; and Department of Neuroscience (JJF), The Johns Hopkins University School of Medicine, Baltimore, Maryland.
    Search for more papers by this author
  • J. James Frost,

    1. From the Department of Psychiatry and Behavioral Sciences (EMW, GSW, CAM, MEM), The Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Medicine (GSW, MEM), The Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Neuroscience (JJF), The Johns Hopkins University School of Medicine, Baltimore, Maryland; and Department of Radiology (HK, RFD, JH, JJF), The Johns Hopkins University School of Medicine, Baltimore, Maryland; and Department of Neuroscience (JJF), The Johns Hopkins University School of Medicine, Baltimore, Maryland.
    Search for more papers by this author
  • Mary E. McCaul

    1. From the Department of Psychiatry and Behavioral Sciences (EMW, GSW, CAM, MEM), The Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Medicine (GSW, MEM), The Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Neuroscience (JJF), The Johns Hopkins University School of Medicine, Baltimore, Maryland; and Department of Radiology (HK, RFD, JH, JJF), The Johns Hopkins University School of Medicine, Baltimore, Maryland; and Department of Neuroscience (JJF), The Johns Hopkins University School of Medicine, Baltimore, Maryland.
    Search for more papers by this author

Reprint requests: Elise M. Weerts, PhD, Johns Hopkins Bayview, BBRC, 5510 Nathan Shock Dr., Suite 3000, Baltimore, MD 21224; Tel.: 410-550-2781; Fax: 410-550-2780; E-mail:eweerts@jhmi.edu

Abstract

Background:  The endogenous opioid system plays a significant role in alcohol dependence. The goal of the current study was to investigate regional brain mu-opioid receptor (MOR) and delta-opioid receptor (DOR) availability in recently abstinent alcohol-dependent and age-matched healthy control men and women with positron emission tomography (PET) imaging.

Methods:  Alcohol-dependent subjects completed an inpatient protocol, which included medically supervised withdrawal and PET imaging on day 5 of abstinence. Control subjects completed PET imaging following an overnight stay. PET scans with the MOR-selective ligand [11C]carfentanil (CFN) were completed in 25 alcohol-dependent and 30 control subjects. Most of these same subjects (20 alcohol-dependent subjects and 18 controls) also completed PET scans with the DOR-selective ligand [11C]methylnaltrindole (MeNTL).

Results:  Volumes of interest and statistical parametric mapping analyses indicated that alcohol-dependent subjects had significantly higher [11C]CFN binding potential (BPND) than healthy controls in multiple brain regions including the ventral striatum when adjusting for age, gender, and smoking status. There was an inverse relationship between [11C]CFN BPND and craving in several brain regions in alcohol-dependent subjects. Groups did not differ in [11C]MeNTL BPND; however, [11C]MeNTL BPND in caudate was positively correlated with recent alcohol drinking in alcohol-dependent subjects.

Conclusions:  Our observation of higher [11C]CFN BPND in alcohol-dependent subjects can result from up-regulation of MOR and/or reduction in endogenous opioid peptides following long-term alcohol consumption, dependence, and/or withdrawal. Alternatively, the higher [11C]CFN BPND in alcohol-dependent subjects may be an etiological difference that predisposed these individuals to alcohol dependence or may have developed as a result of increased exposure to childhood adversity, stress, and other environmental factors known to increase MOR. Although the direction of group differences in [11C]MeNTL BPND was similar in many brain regions, differences did not achieve statistical significance, perhaps as a result of our limited sample size. Additional research is needed to further clarify these relationships. The finding that alcohol-dependent subjects had higher [11C]CFN BPND is consistent with a prominent role of the MOR in alcohol dependence.

Ancillary